An interventional study of Group Schema therapy and Individual Schema therapy in Borderline Personality Disorder and Randomized Controlled Trial, sponsored by Consorci Sanitari del Maresme. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-12-26.
Sponsored by Consorci Sanitari del Maresme · Not applicable, Interventional, and Treatment
Background and Objectives: Schema therapy has been shown to be of benefit in treating borderline personality disorder. However, it is still unclear what the most suitable treatment implementation format is and to what extent therapeutic gains may be generalizable to regular healthcare settings with limited resources.
Methods: A pragmatic randomized controlled trial was conducted ona representative Spanish sample of outpatients with a DSM-5 main diagnosis of borderline personality disorder. Patients were allocated either to a combined (group plus individual) schema therapy format (n=40) or to a group-only schema therapy format (n=40). Borderline personality disorder severity was the primary outcome, with other clinical variables considered as secondary outcomes (e.g., early maladaptive schemas, functioning). The assessment protocol included baseline, post-treatment (after 12months of treatment), and six-month follow-up evaluations. Data was analyzed through a two-way repeated measures ANOVA. Limitations were a limited follow-up assessment and the absence of multi-center data that detracted from the long-term stability and generalizability of the findings.
336 studies on the registry are indexed under Personality Disorders; 48 are open to participants now.
This study's enrollment of 80 is close to the median of 75 across 229 interventional studies indexed under Personality Disorders.
Browse Personality Disorders studies →Consorci Sanitari del Maresme is the lead sponsor of 15 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Those who will receive both individual plus group schema therapy
Behavioral: Group Schema therapy · Behavioral: Individual Schema therapy
Those who will receive group schema therapy
Behavioral: Group Schema therapy
Bimonthly outpatient psychotherapy delivered in individual setting
weekly outpatient psychotherapy delivered in group setting
BPD (borderline personality disorder) symptomatology
Severity of borderline symptomatology as measured by a single score from the BSL-23 scale (range: 0-92; the higher the score, the more severe the BPD severity).
Time frame: 18 months
global functioning
Severity of dysfunction as measured by a single score from the WHOQoL scale (range: 0-100; the higher the score, the more severe the global dysfunction).
Time frame: 18 months
early maladaptive schemas
Severity of maladaptive schemas as measured by a single score from the YSQ scale (range: 0-450; the higher the score, the more severe the EMS severity).
Time frame: 18 months
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Consorci Sanitari del Maresme